CytomX About Probody Therapeutics Pipeline Partners Investors & News Culture & Careers Different to make a difference Sean A. McCarthy, D. Phil. President, Chief Executive Officer and Chairman Amy C. Peterson, M.D. EVP, Chief Development Officer Carlos Campoy SVP, Chief Financial Officer Jeff Landau SVP, Head of Strategy and Chief Business Officer Alison Joly, Ph.D. SVP, Program and Alliance Management Danielle Olander SVP, Talent and Systems Development Alison L. Hannah, M.D. SVP, Chief Medical Officer Marcia P. Belvin, Ph.D. SVP, Head of Research Lloyd A. Rowland, Jr., J.D. SVP, General Counsel, Secretary and Chief Compliance Officer Xemplary Board of Directors Sean A. McCarthy, D. Phil. President, Chief Executive Officer and Chairman Alan Ashworth, Ph.D., FRS Director Halley E. Gilbert Director Fred Gluck Co-Founder and Director Elaine V. Jones, Ph.D. Director James R. Meyers Director Mani Mohindru, Ph.D. Director John Scarlett, M.D. Director Matthew Young Director Contact Us 151 Oyster Point Blvd, Suite 400 South San Francisco, CA 94080-1913 Offices: 650-515-3185 Fax: 650-351-0353 Share Linkedin Twitter © 2021 CytomX Therapeutics, Inc. | PROBODY, CYTOMX, and our corporate logo are U.S. registered trademarks of CytomX Therapeutics, Inc. IHZ is a trademark of CytomX Therapeutics, Inc. All other brands and trademarks referenced herein are the property of their respective owners. About Overview Vision & Mission Our Values Executive Team Board of Directors Scientific Advisory Board Contact Us Probody Therapeutics Our Probody Approach How Probody Therapeutics Work A Versatile Platform Scientific Publications & Presentations Pipeline Advancing a Pipeline Lead Candidates Clinical Trials Access for HCPs/Patients Partners Opportunities Current Partners Investors & News Corporate Profile Press Releases Events & Presentations Scientific Publications Corporate Governance Stock Information Financial & Filings Analyst Coverage Investor Resources Culture & Careers Overview Xtraordinary Culture Current Openings Total Rewards Program Corporate Amenities Home Terms of use Privacy policy Disclaimer for Twitter